跳至主要内容
临床试验/NCT04167111
NCT04167111撤回不适用

Pilot Study- Treat to Target Vitamin D in End Stage Renal Disease

University of Nebraska0 个研究点开始时间: 2020年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
25(OH)D level

研究概览

简要总结

Feasibility of dose adjustment to reach a 6 month 25-hydroxy vitamin D level of 35-50 ng/ml in end stage renal disease patients

详细描述

Pilot study to test the feasibility of adjusting doses based on a prespecified algorithm to reach a 6 month 25(OH)D level of 35-50 ng/ml in end stage renal disease patients.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Sequential
主要目的
Other
盲法
None

入排标准

年龄范围
21 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • likely be able to complete the study, >3 months on hemodialysis, receiving standard of care through their nephrologist.

排除标准

  • on peritoneal dialysis, allergy to vitamin D, liver disease, intestinal disorders that interfere with vitamin D absorption, taking vitamin D >800 IU per day, 25(OH)D level >30 ng/ml, glucocorticoids, anticonvulsants or drug therapies for osteoporosis, pregnancy.

结局指标

主要结局

25(OH)D level

时间窗: 6 months

25(OH)D level

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验

Pilot Study- Treat to Target Vitamin D in End Stage... | 临床试验